HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of bretazenil against cortical epileptic afterdischarges increases during early ontogeny in rats.

Abstract
The effect of a benzodiazepine partial agonist bretazenil on cortical epileptic afterdischarges was studied in 12-, 18- or 25-day-old rat pups with implanted electrodes. Afterdischarges were induced by low-frequency stimulation of sensorimotor area four times in each animal and bretazenil (0.1; 1; 5; 10; or 25 mg/kg) and/or solvent were administered intraperitoneally between the first and second stimulation. Bretazenil was able to decrease the duration of afterdischarges as well as intensity of clonic seizures accompanying these afterdischarges in all age groups in a dose-dependent manner. The efficacy of bretazenil was age-dependent: the most marked effect on duration of afterdischarges was observed in 25-day-old rats. It is in sharp contrast with our earlier data for full agonists clonazepam and midazolam demonstrating the strongest action in the youngest group.
AuthorsPavel Mares, Romana Slamberová
JournalPharmacological reports : PR (Pharmacol Rep) 2006 Jul-Aug Vol. 58 Issue 4 Pg. 519-25 ISSN: 1734-1140 [Print] Switzerland
PMID16963798 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticonvulsants
  • Benzodiazepinones
  • bretazenil
Topics
  • Age Factors
  • Aging
  • Animals
  • Anticonvulsants (pharmacology, therapeutic use)
  • Benzodiazepinones (pharmacology, therapeutic use)
  • Cerebral Cortex (drug effects, growth & development, physiopathology)
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Electric Stimulation
  • Electrodes, Implanted
  • Electroencephalography
  • Epilepsy (physiopathology, prevention & control)
  • Evoked Potentials (drug effects)
  • Rats
  • Rats, Wistar
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: